فهرست نشریات علمی دسترسی آزاد ایران

Results: Prevalence of anemia was 39% of the patients, eGFR was 58 ± 25 ml/min/1.73m2, body mass index (BMI) was 28±7 kg/m2 mean hemoglobin for all patients was 12±2. There was a significant decrease in hemoglobin level in stage 3 CKD in comparison to stage1 and stage 2. Also there was a significant decrease in hemoglobin level in stage 4 in comparison to stage 1, 2, and 3. We found significant lower eGFR in anemic group 43±20 as compared to nonanemic group 68±22ml/min/1.73m2. Additionally, there was significant lower hemoglobin, hematocrite and eGFR in uncontrolled diabetic patients compared with the controlled ones. Conclusions: Anemia is prevalent among diabetics but remains under-recognized and under-treated. Therefore, we recommend screening of anemia in diabetics even at normal eGFR, and aggressive management of diabetic anemia so as to improve quality of life and outcome for the affected patients. Further studies are recommended to determine a different hemoglobin target in diabetic patients.